How easy is it to order your cell therapy? Unlike off-the-shelf products, Autologous Cell Therapies are made to order for each individual patient – successful and seamless delivery will depend on your ability to map out and clearly understand all the complexities.
This fourth installment of our series focuses on several critical considerations manufacturers must keep in mind as they navigate the complex process of managing individual patient orders from before order placement until final product delivery. The image below can serve as a reference to stimulate thinking during planning & strategy discussions across Marketing, Operations, and Supply Chain & Manufacturing teams.
Download infographic Shaping the Order Management Process for ACT Products
Note on Printing this Infographic: The optimal printing size for this graphic is 11×17 inch paper.
Who We Are: Nuvera LLC is a strategic consulting team focused exclusively on the rare disease and specialty therapeutics with over 10 years in helping our specialty pharma/biotech clients design exceptional treatment support experiences.
Jump to a slide with the slide dots.
The nuvera series touching upon several commercialization issues surrounding Autologous Cell Therapies (ACTs).
Read moreHow the experiences of patients, referring physicians, treatment centers, and the cells themselves relate to each other.
Read moreLearn key insights for seamless execution when Managing ACT stakeholders, from internal teams to third-party partners.
Read moreFrom order management to patient services, a strong ACT tech ecosystem is essential. Discover key strategies to enable seamless integration.
Read more